Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UNIVERSAL BIOSENSORS INC. Director's Dealing 2025

Jan 16, 2025

65977_rns_2025-01-16_84e8bfd2-708e-482f-9db5-3802f189c997.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity: Universal Biosensors, Inc.

ARBN: 121 559 993

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Peter Mullin
Date of appointment 15 January 2025

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

444,424 CDIs (equivalent to 444,424 fully paid ordinary shares).

99,424 quoted options with an expiry date of 8 May 2027 and an exercise price of $0.20 per option.

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

  • See chapter 19 for defined terms.

11/3/2002

Appendix 3X Page 1

Appendix 3X Initial Director’s Interest Notice

Name of holder & nature of Number & class of Securities
interest
Note: Provide details of the circumstances giving rise
to the relevant interest.
Mullin Family Trust (Peter Mullin is 577,000 CDIs (equivalent to 577,000 fully paid
the trustee and beneficiary) ordinary shares).
100,000 quoted options with an expiry date of 8
May 2027 and an exercise price of $0.20 per
option.
Mullin Family Superannuation Fund 1,519,261 CDIs (equivalent to 1,519,261 fully paid
(Peter Mullin is the trustee and ordinary shares).
beneficiary)
275,003 quoted options with an expiry date of 8
May 2027 and an exercise price of $0.20 per
option.

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nil
Nature of interest
Name of registered holder
(if issued securities)
No. and class of securities to which
interest relates
  • See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002